Investor Relations

The Latest:

NDEV is well positioned due to several key factors that are driving its recent momentum:

*Positive Outlook on Rescheduling: The DEA’s first hearing on rescheduling cannabis under the Controlled Substances Act centered on the proposal to reclassify cannabis from Schedule I to Schedule III. This change would allow for tax benefits and reduce research barriers without fully legalizing the substance. The administrative law judge emphasized that the focus is not on whether cannabis is “good or bad” but rather on the merits of its classification. By categorizing substances into different schedules, the government can effectively regulate their distribution, prescribing practices, and penalties for misuse.

*Investor Activity: As banks enter the cannabis sector, these changes may increase investor interest as they prepare to benefit from upcoming federal reforms.

*Sustaining Business Model: The potential rescheduling of cannabis is a key turning point for the industry. As regulations change, Novus is positioned to seize new market opportunities. Even without interstate commerce or the SAFER Banking Act, we can sustain our business model without relying on external funding. Our focus on strong revenue and profitability allows us to reinvest profits, maintaining our independence and commitment to innovation and growth.

*Latest Article by Frank Labrozzi, CEO of Novus, in Healthcare Business Today: New Revenue Streams for Healthcare Providers: Reimbursing for Cannabis Through Health Plans

Quote and Research Links are Below

About Novus: Since 2015, Novus Acquisition & Development Corporation (NDEV), d/b/a Novus Cannabis MedPlanⓇ, has been a pioneer in integrating THC and CBD cannabis into health insurance plans for both medical and recreational cannabis consumers. With over 1,200 agents, brokers, and dispensaries, NDEV generates revenue through insurance premiums and provides policyholders access to affordable treatment options.

The company’s niche is offering cannabis as an alternative to opioids and protecting veterans from VA benefit denials due to participation in state-approved cannabis programs. NDEV’s sustainability is based on its receivable-based business model. It has attracted interest from major carriers and InsurTech platforms for future plan integration.